Lunit Cancer Screening Tech Stack

FDA-cleared AI for cancer screening across chest X-ray, mammography, and digital pathology

Software Development Boston, Massachusetts 201–500 employees Public Company

Lunit builds validated medical AI for radiologic and pathologic cancer detection, deployed across 3,500+ clinical sites globally. The tech stack reveals a dual operating model: production radiology software (PACS, DICOM, HL7 integration) paired with an active ML platform underneath (Kafka, Kubernetes, Airflow, GPU clusters). Current project focus spans oncology biomarkers, digital pathology upgrades, and health-system integration—while pain points cluster around regulatory compliance, EHR interoperability, and scaling distributed training infrastructure. Leadership hiring (Medical Director, plus senior/director-level roles) suggests expansion beyond pure screening into treatment planning.

Tech Stack 37 technologies

Core StackSalesforce Slack Confluence Linux Go Python TypeScript React PostgreSQL Kafka Kubernetes Docker AWS GitHub Actions Prometheus Grafana Loki Apache Airflow Prefect Cursor PACS DICOM HL7 macOS GCP Azure Argo CD Codex ChatGPT Claude+7 more

What Lunit Cancer Screening Is Building

◆Challenges

Developing ai-powered oncology biomarkers
Digital ai biomarker development
Digital pathology ai model upgrade
Increasing demand in korean market
Integration challenges across diverse environments
Large-scale medical data infrastructure
Gpu cluster training stability
Regulatory compliance for ai models
Implementing diagnostic software across health systems
Integrating with ehrs

▲Active Projects

Commercial development of ai-powered oncology biomarkers
Global business projects related to ai-powered oncology biomarkers
Clinical research of ai-powered oncology biomarkers
Digital ai biomarker development
Digital pathology ai model upgrade
Bid and pre/post sales project support
Global ai platform integration for hospitals
Large-scale medical data pipeline
Gpu cluster-based distributed training environment
Implementing lunit breast cancer screening software

Hiring Activity

Accelerating8 roles · 7 in 30d

Department

Engineering

Research

Data

Sales

Support

Seniority

Senior

Director

Manager

Mid

Notable leadership hires: Medical Director

Company intelligence

Find more companies like Lunit Cancer Screening by tech stack, pain points and active projects

Get started free

About Lunit Cancer Screening

Lunit is a Boston-based public company specializing in FDA-cleared AI software for cancer screening and diagnosis. The product portfolio includes Lunit INSIGHT CXR (chest X-ray), Lunit INSIGHT MMG (2D mammography), Lunit INSIGHT DBT (3D breast tomosynthesis), and Lunit CXR Triage (emergency-department chest X-ray, US-only). Clinical validation spans 100+ peer-reviewed publications. Deployment footprint covers 3,500+ sites globally, with active expansion into Korean and US markets. Beyond screening, the company is advancing AI-powered oncology biomarkers and digital pathology, indicating a shift toward treatment and prognosis workflows. The organization operates as an engineering- and research-heavy team managing complex clinical software deployments, health-system integrations, and regulated model development.

HeadquartersBoston, Massachusetts

Company Size201–500 employees

Hiring MarketsSouth Korea, United States

Frequently Asked Questions

What tech stack does Lunit use?

Lunit runs clinical software on PACS, DICOM, HL7 standards, with backend services in Go, Python, TypeScript/React, PostgreSQL, and Kafka. ML pipeline uses Kubernetes, Docker, Apache Airflow, Prefect, and GPU clusters. Cloud deployment spans AWS, GCP, and Azure. Monitoring via Prometheus, Grafana, Loki.

What is Lunit working on?

Current projects include oncology biomarker development (commercial, clinical, and global business tracks), digital pathology model upgrades, global hospital platform integration, large-scale medical data pipelines, and EHR integration across health systems.